Eastman (EMN) Insider Purchase and Deferred-Comp Grant Reported

Rhea-AI Filing Summary

Insider purchases and deferred-compensation award reported for Eastman Chemical (EMN)

Brian Travis Smith, an executive (EVP, AFP, Mfg., WWEC & HSE) reported acquiring 1,750 shares of Eastman common stock at a price of $68.34 per share, bringing his direct beneficial ownership to 16,732 shares. Separately, he was credited with 2,200 phantom stock units under the company Executive Deferred Compensation Plan; those units have a value tied to the company common stock at $68.18 per share and are payable in cash, with the report showing 2,208 underlying shares equivalent following the award. The phantom units are subject to plan terms including limited acceleration and withdrawal provisions and are payable after termination of employment. The filing reflects routine insider equity purchases and a deferred-compensation award that links pay to the issuer stock value.

Positive

• Insider open-market purchase of 1,750 shares at $68.34 demonstrates executive buying of company stock
• Deferred-compensation award uses phantom stock units tied to common stock value, aligning executive pay with shareholder outcomes
• Phantom units are cash-settled, so the award does not dilute outstanding shares

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine insider purchase and deferred-compensation grant, aligns executive pay with shareholder value.

The reported open-market acquisition of 1,750 shares by an executive officer and the grant of phantom stock units are standard governance outcomes that generally signal alignment of management incentives with shareholders. The phantom units are cash-settled and subject to plan acceleration and withdrawal rules, so they do not dilute share count but do tie compensation value to share price movements. This filing is informational and not unusual for senior executives.

Securities Analyst

TL;DR: Small-scale insider purchase; transaction size is modest relative to typical market cap impact.

The purchase of 1,750 shares at the reported price increases the officer s direct holdings to 16,732 shares. While insider buying can be a positive signal, the absolute size here is unlikely to materially affect capital structure or market perceptions absent larger, corroborating transactions. The phantom units represent deferred cash compensation linked to share value rather than issuance of equity, limiting immediate market impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH BRIAN TRAVIS

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, AFP, Mfg., WWEC & HSE

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		1,750	A	$68.34	16,732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	08/28/2025		J		2,200		(1)	(1)	Common Stock	2,200	$68.18	2,208	D

Explanation of Responses:

1. Phantom Stock Units acquired under the Executive Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash and subject to certain acceleration and early withdrawal provisions, after termination of employment. Additional Remarks

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Brian Travis Smith	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for Eastman Chemical (EMN)?

An executive officer acquired 1,750 common shares at $68.34 per share and was credited with 2,200 phantom stock units valued at $68.18 per unit.

Who filed the Form 4 for EMN and what is their role?

The filing reports transactions by Brian Travis Smith, identified as EVP, AFP, Manufacturing, WWEC & HSE, filing as a reporting person.

How many shares does the reporting person own after the reported purchase?

Following the reported acquisition, the filing shows direct beneficial ownership of 16,732 common shares.

What are the phantom stock units reported in the filing?

The filing reports 2,200 phantom stock units under the Executive Deferred Compensation Plan; they are cash-settled, tied to common stock value, and payable after termination under plan terms.

Do the phantom units dilute Eastman Chemical's outstanding shares?

No; the phantom stock units are payable in cash and therefore do not represent newly issued shares or cause dilution according to the filing.